跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMALIDOMIDA KRKA 3 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
POMALIDOMIDA KRKA 3 MG CAPSULAS DURAS EFG
Approved
STANDARD
POMALIDOMIDA KRKA 3 MG CAPSULAS DURAS EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 2, 2024
Approval ID
70a981555da64e21
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
70a981555da64e21
Drug Cima Aemps Name
POMALIDOMIDA KRKA 3 MG CAPSULAS DURAS EFG
Register Number
1241832005
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Krka Farmaceutica S.L.
Authorization Date
2024-08-02
Dosage Form
CÁPSULA DURA
Dose
3 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Krka D.D. Novo Mesto
Active Ingredients
POMALIDOMIDA
3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 2, 2024
Approval ID
70a981555da64e21
Type
Standard
Back to CIMA-AEMPS Approvals